JB Chemicals & Pharmaceuticals shareholding pattern

JBCHEPHARM

2140.4

2.60 (0.12%)
Last updated on 15 May, 2026 | 15:31 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

JB Chemicals & Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

48.8%

Mutual Fund

19%

Insurance

1.33%

Foreign Institutional Investors

16.33%

Domestic Institutional Investors

1.05%

Retail

13.48%

Others

0.01%

Total Promoters
MAR '26
48.8%

Summary

JB Chemicals & Pharmaceuticals share holding pattern reports the following shareholding: JB Chemicals & Pharmaceuticals Total Promoters is at 48.80%, Mutual Fund at 19.00%, Insurance at 1.33%, Foreign Institutional Investors at 16.33%, Domestic Institutional Investors at 1.05%, and Retail at 13.48%. This breakdown provides a quick snapshot of ownership distribution for JB Chemicals & Pharmaceuticals share holding pattern in 2026-27.

JB Chemicals & Pharmaceuticals FAQs

As of 05-2026, the promoter shareholding in JB Chemicals & Pharmaceuticals stands at 48.8% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of JB Chemicals & Pharmaceuticals is 16.33% and 1.05% respectively.

The retail shareholding of the JB Chemicals & Pharmaceuticals is 13.48%.

Changes in shareholding patterns of JB Chemicals & Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of JB Chemicals & Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost